Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Francy87
    Member
    • May 2013
    • 28

    #1

    mRNA traces on Bioanalyzer

    I know it's a discussed argument, but I'd like to have an opinion about my Bioanalyzer traces.
    I extracted total bacterial RNA from food samples, then I used the Bacteria RiboZero kit to purify from rRNA. I don't know how my total RNA looked like before the RiboZero depletion, since I didn't run it on the BioAnalyzer, but after the rRNA depletion it looked like in the BA traces attached.

    The sequencing core said I can't go ahead with the library preparation… But I saw on the RiboZero website that after the purification, I should have only a peak at 100-140nt, that is what I have. I can't understand why my traces are different from what epicenter write on the website.
    Any comments about this? Does anyone has ever obtained libraries from this kind of mRNA?
    Attached Files
  • littlefairy
    Junior Member
    • Dec 2013
    • 2

    #2
    Hi,
    Sorry I can not answer your questions
    Could you please tell me how to print the xad file to pdf like what you did.
    Thanks

    Comment

    • nucacidhunter
      Jafar Jabbari
      • Jan 2013
      • 1250

      #3
      Originally posted by littlefairy View Post
      Hi,
      Sorry I can not answer your questions
      Could you please tell me how to print the xad file to pdf like what you did.
      Thanks
      On Agilent 2100 Expert software go to File>print which will open a print dialogue box. In the box under “Save To File” section tick PDF box.

      Comment

      • littlefairy
        Junior Member
        • Dec 2013
        • 2

        #4
        That works well.
        Thanks a lot.
        Hopefully, you will solve the problem.
        By the way, my total prokaryotic RNA sample yesterday is of low RIN value, merely 6, which means RNA-seq could not be done on this samples.

        Comment

        • pmiguel
          Senior Member
          • Aug 2008
          • 2328

          #5
          Originally posted by Francy87 View Post
          I know it's a discussed argument, but I'd like to have an opinion about my Bioanalyzer traces.
          I extracted total bacterial RNA from food samples, then I used the Bacteria RiboZero kit to purify from rRNA. I don't know how my total RNA looked like before the RiboZero depletion, since I didn't run it on the BioAnalyzer, but after the rRNA depletion it looked like in the BA traces attached.

          The sequencing core said I can't go ahead with the library preparation… But I saw on the RiboZero website that after the purification, I should have only a peak at 100-140nt, that is what I have. I can't understand why my traces are different from what epicenter write on the website.
          --
          Phillip
          Any comments about this? Does anyone has ever obtained libraries from this kind of mRNA?
          Pico chips are very sensitive. So the lack of any visible mRNA makes it seem like nearly all of your sample was lost and/or degraded during purification.

          Comment

          • kerplunk412
            Senior Member
            • Jun 2012
            • 119

            #6
            I agree that it looks like your RNA is degraded. It would be a good idea to check your samples on the BA (or by agarose gel) before starting the depletion to determine if the problem arose from your samples or the rRNA depletion process. It is always a good idea to assess the quality of your starting material before starting purification and library prep.

            If these are very precious samples you might still be able to make libraries from them, but you should probably skip fragmentation and possibly modify bead cleanup steps to retain smaller products.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
              by SEQadmin2



              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

              Despite this, “CRISPR helped turn genome editing from a specialized technique into
              ...
              07-31-2026, 11:01 AM
            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 08-13-2026, 12:22 PM
            0 responses
            31 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-11-2026, 10:35 AM
            0 responses
            24 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-06-2026, 07:41 AM
            0 responses
            38 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-03-2026, 10:13 AM
            0 responses
            51 views
            0 reactions
            Last Post SEQadmin2  
            Working...